Medivir

Medivir
Country: Sweden
State: Non USA
Sector: Pharmaceuticals
Quotation Market: OMX
Board Description:

Medivir is a high-growth Nordic pharmaceutical company focusing on successful research activities and with a Nordic sales organisation.The company was founded in 1988 as a spin-off from AstraZeneca’s antiviral research unit. Medivir was listed on the NASDAQ OMX, Stockholm Stock Exchange Mid Cap List for medium-sized companies in 1996.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.